Engineering Cocrystals of Poorly Water-Soluble Drugs to Enhance Dissolution in Aqueous Medium
Biopharmaceutics Classification System (BCS) Class II and IV drugs suffer from poor aqueous solubility and hence low bioavailability. Most of these drugs are hydrophobic and cannot be developed into a pharmaceutical formulation due to their poor aqueous solubility. One of the ways to enhance the aqu...
Main Authors: | Indumathi Sathisaran, Sameer Vishvanath Dalvi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-07-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4923/10/3/108 |
Similar Items
-
Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs
by: Anna Karagianni, et al.
Published: (2018-01-01) -
Cocrystals by Design: A Rational Coformer Selection Approach for Tackling the API Problems
by: Maan Singh, et al.
Published: (2023-04-01) -
Combining a Drug and a Nutraceutical: A New Cocrystal of Praziquantel and Curcumin
by: Camila Caro Garrido, et al.
Published: (2024-02-01) -
Synthesis and Characterization of a New Norfloxacin/Resorcinol Cocrystal with Enhanced Solubility and Dissolution Profile
by: Hanan Fael, et al.
Published: (2021-12-01) -
Investigation of possible solubility and dissolution advantages of cocrystals, I: Aqueous solubility and dissolution rates of ketoconazole and its cocrystals as functions of pH
by: Jaydip M. Vasoya, et al.
Published: (2019-04-01)